vimarsana.com
Home
Live Updates
Oncocyte Corporation Announces Proposed Public Offering of :
Oncocyte Corporation Announces Proposed Public Offering of :
Oncocyte Corporation Announces Proposed Public Offering of
IRVINE, Calif., April 13, 2022 (GLOBE NEWSWIRE) -- Oncocyte Corporation (Nasdaq: OCX), (“Oncocyte” or the “Company”), announced today that it has...
Related Keywords
New York ,
United States ,
Bob Yedid ,
Megan Kernan ,
Lifesci Advisors ,
Company Determa ,
Company Annual Report On Form ,
Needham Company ,
Exchange Commission ,
Syndicate Prospectus Department ,
Oncocyte Corporation ,
Insight Genetics Inc ,
Chronix Biomedical Inc ,
Life Technologies Corporation ,
Oncocyte Corporation Nasdaq ,
Collaboration Agreement ,
Thermo Fisher Scientific ,
Oncomine Comprehensive Assay Plus ,
Integrated Sequencer ,
Purification System ,
Chronix Biomedical ,
Insight Genetics ,
Private Securities Litigation Reform Act ,
Risk Factors ,
Annual Report ,
Sci Advisors ,
Nasdaq Ocx ,